PL
ProPhase Labs, Inc.
SEC filingBiotechnology · Uniondale, NY
Amount raised$3Msold at filing
Total offering$6M$3M still open
Investors in the raise2count reported to the SEC
FiledAug 5, 2025first sale Jul 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
LOUIS GECKELDirector
WARREN HIRSCHDirector
CAROLINA ABENANTEDirector
TED KARKUSExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.